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Abstract Nanoinformatics has recently emerged to address the need of computing
applications at the nano level. In this regard, the authors have participated in various
initiatives to identify its concepts, foundations and challenges. While nanomaterials
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open up the possibility for developing new devices in many industrial and scientific
areas, they also offer breakthrough perspectives for the prevention, diagnosis and treat-
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ment of diseases. In this paper, we analyze the different aspects of nanoinformatics
and suggest five research topics to help catalyze new research and development in the
area, particularly focused on nanomedicine. We also encompass the use of informatics
to further the biological and clinical applications of basic research in nanoscience and
nanotechnology, and the related concept of an extended “nanotype” to coalesce infor-
mation related to nanoparticles. We suggest how nanoinformatics could accelerate
developments in nanomedicine, similarly to what happened with the Human Genome
and other -omics projects, on issues like exchanging modeling and simulation methods
and tools, linking toxicity information to clinical and personal databases or developing
new approaches for scientific ontologies, among many others.
Keywords Nanoinformatics · Computing · Nanotechnology · Bioinformatics ·
Medical Informatics · Nanomedicine
Mathematics Subject Classification (2000) 68 · 92
1 Introduction
Over the past five decades many computing methods and applications have arisen in
the context of biomedicine, leading to interdisciplinary areas such as medical infor-
matics, bioinformatics and others [1–3]. These biomedical-related informatics disci-
plines span a wide range of scientific and technological approaches to solve complex
problems, including, among others, data and knowledge integration methods, biomed-
ical ontologies and vocabularies, data and text mining, systems interoperability, DNA
and RNA sequencing, medical decision support, predicting the relationships between
gene mutations and diseases, the development of standards for data representation and
exchange, or the development of informatics methods and tools for integrating multi-
level data and creating multi-scale simulations of biomedical systems. Informaticians
have successfully contributed to these areas, leading to outstanding results such as the
Human Genome and other -omics projects, the computerization of clinical practice or
the creation of computerized systems for decision support [4]. The authors have been
active in informatics research supporting a number of projects in the past decades and
pioneered significant examples such as, among others, medical expert systems [5–7].
After various decades of research on such biomedical systems, a challenging new
field, nanomedicine, which promises to deliver scientific and technological break-
throughs that could transform medicine, is beginning to receive attention from the
scientific community, including informaticians [8].
To our knowledge, no paper has been published, at the time of writing, in the
computing literature about nanoinformatics. Figure 1 presents an analysis of these
references, using the goPubmed [9] facility.
In this context, one particular challenging issue, which remains mostly unexplored,
is the application of computing to nanomedicine. To advance research in this field,
requirements for data, information and knowledge management need to be specified,
and are substantial. While research in this area is commonly associated with nanotech-
nology there are many topics where computational methods are themselves critical to
advance research and support professional practice. For instance, we have identified
123
524 V. Maojo et al.
Fig. 1 A comparative analysis among the references available in Medline with the terms “Nanotechnol-
ogy Informatics”, “Medical Informatics”, “Bioinformatics” and “Biomedical Computing” carried out with
goPubmed [9]. On the left side, is shown the number of publications per year (2000-present); on the right
side, the top terms or most common keywords used in these publications
various areas where significant research in informatics applied to nanomedicine is
already underway [10,11]. These can be summarized in the following non-exhaustive
list:
– Nanoparticle characterization
– Modeling and simulation
– Imaging
– Terminologies, ontologies and standards
– Data Integration and Exchange
– Systems’ interoperability
– Data and text mining for nanomedical research
– Linking nano-information to computerized medical records
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– Basic and translational research
– Networks of international researchers, projects and labs
– Nanoinformatics Education
– Ethical Issues
Nanoinformatics has only recently emerged to address these issues, with the support of
organizations like the US National Science Foundation, the National Cancer Institute
and the European Commission. In this new context, (biomedical or nanomedical) nano-
informatics refers to the use of informatics techniques for analyzing and processing
information about the structure and physico-chemical characteristics of nanoparticles
and nanomaterials, their interaction with their environments, and their applications for
nanomedicine [10,11]. Such new applications emerge in a time where genomic and
personalized medicine are still getting recognition, and promise additional future per-
spectives for biomedicine. We have adopted the term “nanoinformatics” in this paper,
as a contraction and easier form of the broader terms “biomedical nanoinformatics” or
“nanomedical informatics”. Nanoinformatics can be also related to other applications
of nanotechnology but we will address here only biomedical applications.
Given the rapidly advancing extensions of all the informatics issues arising between
molecular biology and systems biology (bioinformatics and computational biol-
ogy) and public health (for public health bioinformatics) in biomedical practice and
research, we can wonder if current informatics applications—e.g., from bioinformatics
or medical informatics—may also be ready to address this new area of nanomedicine.
The latter is considered by many as the new frontier of medicine—at a different, nano
level, which implies significant physical and chemical differences—raising great chal-
lenges for research, medical practice and economic implications due to novel toxic-
therapeutic tradeoffs at the nano level [12–15]. In this regard, we might recall what
happened around 1995–2001, when bioinformatics contributed to the early comple-
tion of the Human Genome Project, and here one can conjecture that informatics
will also be essential to progress in the development of nanomedicine. In addition to
new computing methods and tools, the possibilities of reusing informatics methods,
tools, data and lessons learned may well contribute to speeding up the development
of nanomedicine.
Nanomedicine includes a large number of significant topics of practical and scien-
tific impact, such as, for instance, the early detection of diseases like cancer, the ability
to reach highly specific targets within the body, new molecular imaging methods based
on the optical properties of nanoparticles, methods to control drug delivery at very
low dosages, nanorobots for diagnosis and therapy, and novel approaches to overcome
solubility limitations of new or existing drugs. Readers can access a large number of
reports for further reference [8,12–14].
Let us consider an example. Some of the authors (at the Universidad Politecnica de
Madrid (UPM)) have developed an informatics application, based on text mining tech-
niques, that we have called “the nanotoxicity searcher”, which automatically searches
for toxicity information in the literature. In searches carried out for paclitaxel, infor-
mation about nanotoxicity was found, combined with appropriate ontologies—like the
Nanoparticle Ontology [15] and others such as the Foundational Model of Anatomy
[16]—, and it can be made available to physicians in advance of treatment or linked
to the electronic health record.
123
526 V. Maojo et al.
This research and other efforts [17–20] have raised issues associated with manag-
ing the nanotechnology information, most notably: (a) the lack of adequate standard
classifications of nanomaterials, (b) the rapidly evolving knowledge of the many com-
plex biological, chemical and physical processes occurring at the nano level, and (c) the
heterogeneity of the information content and structure of many scientific papers in the
very diverse nano disciplines and subfields. All of these issues magnify the challenges
of applying standard information extraction and retrieval methods to the literature
without further additional knowledge of the specifics of the fields and subfields rep-
resented. New informatics approaches are needed to efficiently and effectively link
information from nanomedicine, while addressing the various levels of complexity
covered by research, development and translation in nanotechnology.
In this context, the authors have worked in an international collaboration to define
nanoinformatics and propose a roadmap for the field [18]. We present below the main
conclusions of our analysis.
2 A perspective for nanoinformatics applications
In Table 1, we extend the approach we previously used to analyze biomedical infor-
matics, contrasting its medical informatics and bioinformatics components [4]. We
now contrast nanoinformatics with informatics applications in biomedicine according
to six different perspectives.
We expand this comparison below.
2.1 Academic disciplines: development and scientific goals
A “Workshop on Nanoinformatics Strategies,” supported by the National Science
Foundation, was held in Arlington, Virginia in 2007 [17], followed by various confer-
ences. This workshop focused on practical engineering perspectives, without including
existing computing infrastructures. Given the relatively short time since this meeting
took place, only a few references can be found in the literature at the time of writing;
however, an increasing number of web references show that nanoinformatics is evolv-
ing rapidly. Since nanotechnology is involved in issues beyond medical and biological
domains, we can anticipate how the use of nanomaterials may have an impact on health
issues.
2.2 Scientific content and informatics goals
The past decade has seen considerable efforts to correlate molecular and clinical
data for scientific discovery, which have led to significant achievements. However,
the semantic heterogeneity, the inherent complexity and uncertainty associated with
linking information from these disparate biological levels has demonstrated the diffi-
culties in fulfilling the original expectations of the application of -omics information
and knowledge to clinical practice and prognosis [21,22]. With nanomedicine, these
difficulties can be expected to increase, but their promise is also great.
From a scientific perspective, very distinctive quantum effects and size-related phe-
nomena take place at the nanoscale. In nanoscience, physicists and chemists have
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Table 1 Feature comparison and contrast between informatics applications in biomedicine and
nanoinformatics
Discipline features or
dimensions
Feature comparison and contrast
Informatics applications in bio-
medicine
Nanoinformatics applications
1. Academic discipline, level
of development and
interdisciplinary links
• Increasing number of
professionals and journals
dedicated to the area
• Recent proposal: 2007
(USA and Europe). An area
still awaiting definition,
with two possible
directions: (a) as part of the
continuum within the
spectrum of biomedical
engineering or biomedical
informatics or (b) towards a
computing discipline,
deeply anchored in
chemistry and physics
• Synergy has proved
beneficial for both medical
informatics and
bioinformatics
2. Scientific content and
informatics goals
• Need to link and integrate
molecular, cellular and
clinical data for scientific
discovery.
• Differences at the biological
nano level suggest that BMI
approaches will have to be
modified—e.g., ontologies,
data integration, simulation
• Genomic medicine and
personalized medicine more
complicated than expected,
but results raise great
expectations
• Challenges in basic research
(nanoscience) might lead to
applications in clinical
medicine—research on
areas like nanoparticles for
imaging, targeting or drug
delivery.
• The term “Information” at
the core of biomedical
informatics and its
name—however, still
lacking a
biologically-focused
information theory
• Is there a niche for
translational research, from
basic nanotechnology to
nanomedical applications?
• Optimally biomedical
informatics will translate
basic research into
personalized medical
advice for patients
3. Integrating data and
knowledge: quality,
availability and collection
of data, networks,
databases, interoperability,
semantic issues,
standardization and
information retrieval
• Many specialized public
databases, few with clinical
data
• Clinical trials of
nanoparticles include issues
of security and patient
safety
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Table 1 continued
Discipline features
or dimensions
Feature comparison and contrast
Informatics applications in
biomedicine
Nanoinformatics applications
• Classical standards updated
to integrate genomic
information
• New validated standard
methods needed
• Large ontological initiatives
and collaborative
bioportals.
• Leverage existing
databases, ontologies and
tools
• Text mining used to capture
knowledge from medical
sources.
• Create and administer
massively large
public/private datasets and
infrastructures (like
caNanoLAB) or build the
tools for interoperability.
• Challenges to link
information from the
genotype to phenotype
• Metadata and annotations
are nuanced by namespace
4. Tools to support
professional practice
• Many recent proposals for
low-cost electronic health
records, with data shared by
patients and organizations,
facing security and privacy
issues
• Nanosurgery and nanobots:
futuristic scientific
challenge
• Significant successes, still
needing wider acceptance
by professionals
• Prevention:
nanobiomarkers,
nanoparticles for disease
detection
• Increasing costs of new
preventive approaches
(biomarkers, routine
genome sequencing, etc.,
for genomic medicine) may
be a burden for national
health systems.
• Open information
management tools needed
• Early genetic detection may
improve (or threaten?) the
lives of citizens—ethical
issues
• Nanotechnology research
very expensive, but
nanoinformatics requires
limited funding
• Economic and social needs
demand new
approaches—small number
of open source tools in
clinical practice, compared
to bioinformatics
• Enormous commercial
prospects
• Proprietary issues—e.g.,
nanoparticles
5. Methods and tools to
support research: signal
processing, imaging and
visualization, modeling
• 3-D image processing and
graphic visualization, from
molecular structures to the
whole body for scientific
research—e.g., the
• Nanoparticles for new
imaging methods
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Table 1 continued
Discipline Features
or Dimensions
Feature comparison and contrast
Informatics applications in
biomedicine
Nanoinformatics applications
European Virtual
Physiological Human and
US initiatives on integrative
physiology
• NLM’s Centers for
Biomedical Computing
addressing challenging
areas
• Modeling, simulation
(nanoHUB: a Web-based
pool of nano resources) and
characterization of
nanoparticles
• Open data and tools still
scarce
6. Education and training MI
and BI professionals: Role
as scientists, engineers and
information brokers
• Many MSc and PhD
programs focused on an
interdisciplinary
approaches
• No current nanoinformatics
programs, could be created
based on BMI experiences
and lessons learned
• E-learning tools, also
applied for education in
developing countries
• Informatics tools will help
professionals to address an
extremely wide scope
(including chemistry and
physics)
• Experts in both
areas—basic science and
clinical practice—needed to
act as information brokers.
shown that bridging orders of magnitude in scale introduces additional scientific
challenges. Although the basic quantum laws of physics required at the nanoscale
are well known, additional models and tools are needed to compute the interactions
between nanoparticles and biomolecules and to compare the results from these mod-
els with experimental measurements. For instance, research on quantum dots or the
development of new nanoparticles for drug delivery benefit from new data, informa-
tion, theory and models of the changes in physical characteristics of materials at the
nanoscale versus in bulk, that were not previously available or known. In this context,
many molecular tools in use for bioinformatics cannot be directly applied—while
others can—, and as a result substantial contributions from the field of multi-scale
modeling and simulation holds the promise of expanding the scope of biomedical
engineering and informatics—in areas such as imaging.
2.3 Integrating data and knowledge
Structuring information in nanomedicine is essential for advancing research. The term
“nanoparticle” was introduced in 2007 [23] in MeSH, the controlled vocabulary used
in Pubmed for organizing and indexing the biomedical literature. New taxonomies
and ontologies, such as the Nanomedicine Taxonomy (NT) [24] and the Nanoparticle
Ontology (NPO) [15], have been developed. Other initiatives include an ontology for
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discovery of new nanomaterials, the Nanotech Index Ontology, as well as the adoption
of applications such as BiomedGT to map among different ontologies [19]. Efforts
like the NPO can contribute to data collection, information classification, search and
retrieval, data and text mining. By annotating nanoparticles, professionals can access
information from previous research and discover knowledge that might reside in such
information. Such work can expand the scope of biomedical ontologies—like those
included in the Open Biological and Biomedical Ontologies (OBO) Foundry [25].
2.4 Tools to support professional practice
Selection of nanomaterials for medical diagnosis and therapy should be based on cri-
teria such as size, shape, topology, composition, pharmacokinetics, biologic activity
or toxicity. The nanoinformatics methods and tools that are needed would require
extensions of those already developed—for example, tools for integrating -omics and
clinical data. Although nanoinformatics is in its initial phase of development, the
opportunities for computer specialists to contribute expertise and applications in nano-
medicine will be great.
Several of the present authors have already carried out research on methods to auto-
matically extract information from the literature—primarily in bioinformatics [26]
but also medical informatics1. We are now extending these efforts by working on an
inventory of nano-resources, which would expand previous ones in the direction of
nanoinformatics. Figure 2 shows a classical diagram reflecting the scope of biomedi-
cal informatics, with different research at various levels of granularity. We have added
screenshots of our own three developments—for bioinformatics, medical informatics
and nanoinformatics, related to each specific topic.
2.5 Methods and tools to support research
Over the past decade, a large number of significant initiatives have been launched—
for example, the National Centers for Biomedical Computing (USA) and the Virtual
Physiological Human (VPH) programme (Europe) [28]—for supporting biomedical
engineering and informatics nationally and internationally. For instance, some of the
authors’ work has been within the context of the VPH, which supports a large number
of projects addressing modeling and simulation of various systems, organs, tissues,
and cells of the body, and their linking to clinical applications. Meanwhile, related
efforts have been funded in the USA, usually with basic research objectives. Both
approaches—clinical and basic research—can be highly complementary. Many engi-
neering approaches and tools that were developed for signal processing, imaging,
modeling and simulation could be adapted in the future for nanoinformatics projects
such as characterizing, modeling and simulating the behavior of nanoparticles used to
target specific molecules within the body, or developing new imaging techniques using
quantum dots for clinical research and practice, as mentioned above. Various reposito-
ries containing modeling and simulation tools are already available for nanotechnology
1 De la Calle G, Nkumu-Mbomio N, Garcia-Remesal M, Maojo V. e-MIR2: tidying up medical informatics
resources (in preparation).
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Fig. 2 Examples of the automated tools developed by some of the authors at the UPM to address the
automated creation of inventories of informatics resources—e.g., databases, software tools, services, etc.
Screenshots of the applications developed at the UPM—from left to right, related to the inventories of
resources for the nanoinformatics, bioinformatics and medical informatics fields—are linked to specific
areas from Shortliffe’s diagram of the various levels of biomedical informatics [27]
applications (such as nanoHUB [29]) and can be expanded through adoption of com-
putational capability. In contrast, proprietary issues regarding nanoparticle design and
development will add new issues to traditional computational approaches. The use
of open source tools and data in nanoinformatics could also facilitate linkage in the
future. An example of current facility, already available in the USA, is the cancer
Nanotechnology Laboratory portal (caNanoLAB) [30]. Another initiative of interest,
previously mentioned, is nanoHUB, a resource for nanoscience and technology created
by the National Science Foundation-funded Network for Computational Nanotechnol-
ogy [29]. It includes applications, professional networking, and interactive simulation
tools for nanotechnology. Similarly, some of the authors, at the University of Talca, in
Chile, in collaboration with members of the Advanced Biomedical Computing Center
at the NCI-Frederick, have developed a pilot database of nanoparticle structures, the
Collaboratory for Structural Nanobiology (CSN) [31].
2.6 Education and training MI and BI professionals
In the case of nanomedicine, the challenges and complexities of the field appear
somewhat parallel, though possibly even more difficult than those that faced
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Fig. 3 Nanoinformatics in the context of Medicine and related disciplines and fields
bioinformaticians earlier in the context of the Human Genome Project. Education
in nanomedicine and nanoinformatics requires adding content from areas such as
advanced quantum physics and chemistry, including new models of imaging, multi-
scale modeling, and others. These new topics considerably extend past computational
research and would add much to current curricula of medical schools. Professionals
with expertise in nanoinformatics applications will have an important role as informa-
tion brokers, connecting people with diverse backgrounds. In such future academic
programs for education in nanoinformatics and nanomedicine, informatics tools will
play a decisive role for students and professionals by helping them to represent and
manage the concepts and knowledge needed, without having to become quantum phys-
icists or chemists. Similarly, the latter can acquire knowledge about nanoinformatics
to participate in research in the field.
Figure 3 graphically depicts nanoinformatics as a related field to Medicine and
other computer-related fields.
3 Five significant areas of research where BMI should influence
nanoinformatics
We present below our ideas about five areas of research where the expertise and
the lessons learned in the Human Genome and other -omics projects, the European
Virtual Physiological Human programme, and projects related to basic and translational
123
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Fig. 4 Five challenging areas for future nanoinformatics research
research, may help develop nanoinformatics and its applications to nanomedicine.
Since the number of topics can be very large, we have focused our attention on a few
particularly significant challenges (see Fig. 4).
3.1 Area 1: data, repositories and standards
The most urgent need for a nanoinformatics infrastructure is to collect, curate, anno-
tate, organize and archive the available data. In addition to archiving the data, expert
annotations and analysis regarding its quality and extent of validity, the infrastructure
should allow for a federated system of public/private databases with adequate, layered
access control to allow aggregation among public and private data where possible.
The development or expansion of databases, software tools or repositories for nano-
particles, and, for example, their nanotoxicity, will allow the exchange of information
about the actual 3-D structures of nanoparticles and nanomaterials and data about the
physical and chemical properties of nanoparticles with biomedical applications. Since
BMI professionals have built thousands of biomedical databases, their experience will
be very valuable in building the required database infrastructure (Table 2).
3.2 Area 2: interoperability: semantic search and ontologies
An important need for nanoinformatics is to begin to federate the mostly isolated data
silos that currently exist in different institutions. One example of such a federated
system is caNanoLAB [30]. In this regard, semantic interoperability of heterogeneous
information systems containing nano and other information will be a key issue in
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Table 2 Summary of challenges for Area 1
• Creation of a Nanoinformatics infrastructure to collect, curate, annotate, organize and archive the
available data
• Design of extended web nano portals, linking groups and information around the world to facilitate data
sharing
• Development of repositories/databases of use cases, clinical trials experiments, databases and nano-
related informatics tools with nano-data, facilitating the reuse of the data—like Arrayexpress for genomic
data.
• Incorporation of regulatory aspects (standards, issues related to open data and source tools, quality
control)
Table 3 Summary of challenges for Area 2
• Intercommunicate among different nanoportals, facilitating rapid sharing of data and other resources
• Improve classification approaches by creating new hierarchies/taxonomies based on actual physical,
chemical, biological, clinical, toxicological characteristics
• Use cloud-computing services and supercomputers to carry out complex computational tasks, such as
simulating interactions between nanoparticles and cells of the human body and supporting research in
multiscale modeling.
• Establish standards for reporting/publishing results in the nanoparticle/nanotechnology research
literature.
nanoinformatics, which will benefit from previous experiences [32]. Similarly, we
have found in our early work on informatics methods for accessing the scientific lit-
erature related to nanomedicine that publications in the nano areas are ill structured,
which makes information retrieval and extraction difficult. Improving the structure
of abstracts and publications to facilitate such tasks has been already proposed in
bioinformatics [33] (Table 3).
A related challenge involves building classifications of nanoparticles. Such clas-
sification approaches could be very helpful in creating new hierarchies/taxonomies
based on actual physical/chemical/clinical/toxic/spatial characteristics, and be sup-
plemented by detailed structural information as it becomes available. Some of the
authors are currently working to develop new “morphospatial” taxonomies or ontol-
ogies [34], analyzing various examples from biomedical imaging, which can be also
applied to nanoparticles. Current ontologies are based on different types of qualitative
information and knowledge, but they cannot help in managing different, quantitative,
visual/graphical types of information and knowledge that are included, for instance,
in shapes, forms and volumes, such as those needed for nanoparticles.
3.3 Area 3: extension of virtual integrative physiological programs
BMI researchers have created a large number of models and simulation tools that could
be reused or adapted to nanomedicine. For instance, 3-D representations and visualiza-
tions of molecular structures [35,36] which can be adapted to visualize nanoparticles.
Adding significant information for understanding changes in the genotype induced
by interactions with nanomaterials could possibly provide new foundations and
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Table 4 Summary of challenges for Area 3
• Reuse the large number of models and simulation tools which have been created by BMI researchers to
adapt them to nanomedicine.
• Create a hypothetical, extended “ nanotype” to allow cataloging of nanoparticles and their biological
targets, their interactions in biological environments, their potential nanotoxicities and their relation to
different diagnostic and therapeutic uses
• Simulate “in silico” the effects, reactions or toxicity of new compounds or materials before “in vivo”
studies and correlate both in silico and in vivo results to in vitro assay results. Multilevel simulations might
predict effects of nanoparticles, provide better in vitro methods, and reduce the need for animal studies.
• Initiate theoretical studies of the interactions between nanoparticles with the most common components
of human cells
Table 5 Summary of challenges for Area 4
• Data and knowledge integration at the nano level, different to what has been already done between
clinical and -omics data at larger scales.
• The structural nature of nanomaterials and the unknown effects of many nanoparticles must be investigated
independently of ontological analyses
• Imaging. A key issue is to create new contrast agents to target specific organs, functions, or cell types
and new imaging methods that are based on nanotechnogical advances
explanations for phenotypical traits. A hypothetical “nanotype”—as we have named
it—could include a large catalog of nanoparticles and biological targets, their inter-
actions, potential nanotoxicities and relations to different diagnostic and therapeutic
medical uses. An example is provided by the Protein Data Bank (PDB) [37], which
could be redesigned and extended to include nanotechnology applications (Table 4).
3.4 Area 4: translational nanoinformatics
Given that many molecular-level processes increasingly involve new atomic-level
or nano-level measurements and understanding, bioinformaticians aims to carry out
translational research to transform the increasing amount of -omics data into new
knowledge that can provide, among other results, personalized medical diagnosis and
therapy for patients by taking into account the complexity of multi-gene and envi-
ronmental interactions in human diseases. Similarly, nanomedicine requires novel
insights beyond the current informatics technology that is typically focused on col-
lecting, representing and linking information that is usually heterogeneous. Another
challenge would be to develop a nomenclature for nanomaterials. Analyzing structures
and information at the nano level may require incorporating new assumptions beyond
those considered in BMI (Table 5).
Many current nanoinformatics applications look very similar—at least, on the sur-
face—to comparable systems already built. In this context, researchers begin to face
unique challenges that nano brings to informatics as we have mentioned above, such
as the polymorphic and polydispersed nature of nanomaterials and the as yet unknown
effects of many nanoparticles. These variabilities imply a substantial added require-
ment for expert annotation and curation of data and analyses to inform scientists
about the quality and reliability of the data, test methods, analyses and models used in
nanomedicine. Establishing better methods for curation by digital means (e.g., wikis)
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Table 6 Summary of challenges for Area 5
• To manage nanomedicine-related data. New standards will be needed for storing data, augmenting
clinical vocabularies and terminologies or exchanging electronic medical information
• Questions related to patient safety and possible secondary effects related to the use of nanoparticles need
to be addressed and managed with nanoinformatics tools
• The creation of large databases that would store nano-related information can be complemented by new
approaches to building EHRs. It will require a collaborative effort from a number of researchers, including
international initiatives—e.g., USA-Europe
could provide another means of accessing literature and data. Such challenges need
to be addressed prior to semantic or ontological analyses, and may well influence
the new area of translational nanoinformatics, already proposed elsewhere [38]. That
is, it will be used in defining the information needed to advance the science and the
translation to clinical medicine.
3.5 Area 5: linking nano information to the electronic health record (EHR)
One of the clearest challenges of nanoinformatics is to link nanomedicine-related data
to patient EHRs. Diagnostic and therapeutic methods based on new nanomaterials
can enhance proposals for personalized medicine—mostly based on -omics advances.
To manage the new, nano-related information—and create potential tools for helping
with decision making—new models of EHRs must be developed (Table 6).
To accomplish this, new extensions to current standards—such as SNOMED or
HL7, for instance—, must be developed to incorporate nano-related information, ter-
minologies and procedures. Then, how can researchers extract useful clinical informa-
tion and predictive therapeutic rules from large sets of data obtained through clinical
trials of therapeutics containing nanomaterials? How could a physician anticipate the
possible therapeutic and toxic effects of nanoparticles for a specific patient?
Despite their benefits, using nanoparticles for therapeutic purposes may involve
hazards for patient safety due to their potential secondary effects, which are often
reported in the literature. In this context, nanoinformatics methods and techniques
can significantly contribute to automatically extracting and organizing the specific
nanotoxicology information available in scientific papers, and make it available for
clinicians and researchers. We have already conducted research along these lines, by
applying text mining techniques to automatically identifying and extracting nano-
toxicology-related entities from the scientific articles2. This includes, for instance,
names and types of nanoparticles—e.g. carbon nanotubes, fullerenes, etc.—, routes
of exposure to the nanoparticles—e.g. inhalation, dermal contact, etc.—, potential
targets—e.g. organs or anatomic locations—or toxic effects of nanoparticles such as
destruction, inflammation, etc. The extracted information can be used for many dif-
ferent purposes, such as indexing and retrieving scientific papers with the different
2 García-Remesal M, García-Ruiz A, Pérez-Rey D, de la Iglesia D, Fritts M, Cachau R, Kulikowski CA,
Maojo V (2011) Automatically extracting nanotoxicology-related entities from the literature (in prepara-
tion).
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entities appearing in them, automatically finding relationships between the detected
entities, or automatically linking and aligning existing nanoinformatics and biomed-
ical ontologies. This kind of research actually addresses three of the five challenges
suggested above: (1) data and knowledge storage and management, (2) nano-ontolo-
gies and semantic searches and (3) extending traditional Electronic Health Records to
include nano-related information.
4 Conclusions
Various fundamental issues arise when analyzing this new field of nanoinformatics.
These include, for instance, the large number of different computing applications that
already emerge to cope with the different areas and topics of nanomedicine and nano-
technology, the large number of papers already indexed in bibliographic databases for
nanotechnology and nanomedicine, the number of companies and nanotechnologists
working with nanotechnological and nanomedical issues, the medical expectations of
nanomedicine—promising to deliver breakthrough advances in various aspects of bio-
medicine—and the economic and ethical implications of this research. The growing
importance of the field will lead professionals in the area to develop, in one way or
another, the necessary nanoinformatics approaches. These will pose a wide range of
new research challenges.
By analyzing nanoinformatics, we can highlight various strong issues that involve
building large databases, developing data and information standards, creating and
mapping domain ontologies, linking related information (formerly, biological, and
now, nano-related) to the computerized medical record, or assimilating new medical
imaging techniques. In this regard, some unique scientific issues arise.
The enormous challenges that nanotechnology and nanomedicine present require
a significant investment to accelerate current research. Informatics requirements are
similar to what was faced in the genomic and post-genomic research projects that
transformed biomedicine. In this regard, the current activity of the authors, from three
different continents, working together over the last 3 years in various nanoinformatics-
related research activities, illustrates the opportunities that international collaborations
can provide to advance this new field.
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